Male Androgenetic Alopecia
June 2008
in “
Springer eBooks
”
Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Research cited in this study 28
- Genetic Variation in the Human Androgen Receptor Gene Is the Major Determinant of Common Early-Onset Androgenetic Alopecia
- The E211 G>A Androgen Receptor Polymorphism Is Associated With a Decreased Risk of Metastatic Prostate Cancer and Androgenetic Alopecia
- Is Baldness Bad for the Heart?
- Evaluation and Treatment of Male and Female Pattern Hair Loss
- Minoxidil: Mechanisms of Action on Hair Growth
- An Open, Randomized, Comparative Study of Oral Finasteride and 5% Topical Minoxidil in Male Androgenetic Alopecia
- Genetic Basis of Male Pattern Baldness
- Use of Finasteride in the Treatment of Men With Androgenetic Alopecia
- Androgen-Inducible TGF-β1 from Balding Dermal Papilla Cells Inhibits Epithelial Cell Growth: A Clue to Understanding Paradoxical Effects of Androgen on Human Hair Growth
- A Randomized Clinical Trial of 5% Topical Minoxidil Versus 2% Topical Minoxidil and Placebo in the Treatment of Androgenetic Alopecia in Men
- The Prevalence and Types of Androgenetic Alopecia in Korean Men and Women
- Polymorphism of the Androgen Receptor Gene Is Associated with Male Pattern Baldness
- The Hair Follicle: A Paradoxical Androgen Target Organ
- Differences in Hair Follicle Dermal Papilla Volume Are Due to Extracellular Matrix Volume and Cell Number: Implications for the Control of Hair Follicle Size and Androgen Responses
- Changes in Hair Weight and Hair Count in Men with Androgenetic Alopecia After Application of 5% and 2% Topical Minoxidil, Placebo, or No Treatment
- The Psychosocial Consequences of Androgenetic Alopecia: A Review of the Research Literature
- Serum Androgens and Genetic Linkage Analysis in Early Onset Androgenetic Alopecia
- Risk Factors for Prostate Cancer: A Case-Control Study in Greece
- Finasteride in the Treatment of Men with Androgenetic Alopecia
- Genetic Analysis of Male Pattern Baldness and the 5α-Reductase Genes
- Androgen Induction of Follicular Epithelial Cell Growth Is Mediated via Insulin-like Growth Factor-I from Dermal Papilla Cells
- Personality Disorders and Psychopathologic Symptoms in Patients with Androgenetic Alopecia
- Diagnostic and Predictive Value of Horizontal Sections of Scalp Biopsy Specimens in Male Pattern Androgenetic Alopecia
- Relations Between Sex Hormone Levels and Characteristics of Hair and Skin in Healthy Young Men
- Hair Growth Effects of Oral Administration of Finasteride, a Steroid 5 Alpha-Reductase Inhibitor, Alone and in Combination with Topical Minoxidil in the Balding Stumptail Macaque
- Five-Year Follow-Up of Men with Androgenetic Alopecia Treated with Topical Minoxidil
- The Comparative Histopathology of Male-Pattern Baldness and Senescent Baldness
- The Inheritance Of Common Baldness: To Be Or Not To Be?
Related research 9
- Pharmacological Therapeutics in Androgenetic Alopecia
- Minoxidil to Treat Androgenetic Alopecia in Men and Women: What Is It and How Does It Work?
- Hairless or Fertile? Finasteride Leads to Epididymal Changes and Infertility in Rats
- Hair Loss in Women: Medical and Cosmetic Approaches to Increase Scalp Hair Fullness
- Androgens and Alopecia
- Androgenetic Alopecia: Pathogenesis and Potential for Therapy
- The Effects of Finasteride on Scalp Skin and Serum Androgen Levels in Men with Androgenetic Alopecia
- Clinical Updates in Hair
- The Effect of Finasteride, a 5 Alpha-Reductase Inhibitor, on Scalp Skin Testosterone and Dihydrotestosterone Concentrations in Patients with Male Pattern Baldness